187 related articles for article (PubMed ID: 15482232)
1. Telithromycin.
Spiers KM; Zervos MJ
Expert Rev Anti Infect Ther; 2004 Oct; 2(5):685-93. PubMed ID: 15482232
[TBL] [Abstract][Full Text] [Related]
2. Telithromycin: an oral ketolide for respiratory infections.
Bearden DT; Neuhauser MM; Garey KW
Pharmacotherapy; 2001 Oct; 21(10):1204-22. PubMed ID: 11601667
[TBL] [Abstract][Full Text] [Related]
3. Telithromycin: the first ketolide antibacterial for the treatment of community-acquired respiratory tract infections.
Lorenz J
Int J Clin Pract; 2003; 57(6):519-29. PubMed ID: 12918892
[TBL] [Abstract][Full Text] [Related]
4. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin.
Fogarty CM; Kohno S; Buchanan P; Aubier M; Baz M
J Antimicrob Chemother; 2003 Apr; 51(4):947-55. PubMed ID: 12654763
[TBL] [Abstract][Full Text] [Related]
5. Telithromycin: the first of the ketolides.
Shain CS; Amsden GW
Ann Pharmacother; 2002 Mar; 36(3):452-64. PubMed ID: 11895060
[TBL] [Abstract][Full Text] [Related]
6. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
Felmingham D
J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
[TBL] [Abstract][Full Text] [Related]
7. Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections.
Yassin HM; Dever LL
Expert Opin Investig Drugs; 2001 Feb; 10(2):353-67. PubMed ID: 11178347
[TBL] [Abstract][Full Text] [Related]
8. The ketolides: a critical review.
Zhanel GG; Walters M; Noreddin A; Vercaigne LM; Wierzbowski A; Embil JM; Gin AS; Douthwaite S; Hoban DJ
Drugs; 2002; 62(12):1771-804. PubMed ID: 12149046
[TBL] [Abstract][Full Text] [Related]
9. Telithromycin (Ketek) for respiratory infections.
Med Lett Drugs Ther; 2004 Aug; 46(1189):66-8. PubMed ID: 15314586
[No Abstract] [Full Text] [Related]
10. Telithromycin.
Wellington K; Noble S
Drugs; 2004; 64(15):1683-94; discussion 1695-6. PubMed ID: 15257629
[TBL] [Abstract][Full Text] [Related]
11. Clinical and bacteriological efficacy of the ketolide telithromycin against isolates of key respiratory pathogens: a pooled analysis of phase III studies.
Low DE; Brown S; Felmingham D
Clin Microbiol Infect; 2004 Jan; 10(1):27-36. PubMed ID: 14706083
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
Mathers Dunbar L; Hassman J; Tellier G
Clin Ther; 2004 Jan; 26(1):48-62. PubMed ID: 14996517
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of ketolides in the treatment of respiratory tract infections.
Reinert RR
J Antimicrob Chemother; 2004 Jun; 53(6):918-27. PubMed ID: 15117934
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against bacterial pathogens from community-acquired respiratory tract infections: data from the first year of PROTEKT (1999-2000).
Kohno S; Hoban D;
J Chemother; 2003 Aug; 15(4):335-41. PubMed ID: 12962361
[TBL] [Abstract][Full Text] [Related]
15. Clinical management of respiratory tract infections in the community: experience with telithromycin.
Quintiliani R
Infection; 2001 Dec; 29 Suppl 2():16-22. PubMed ID: 11785852
[TBL] [Abstract][Full Text] [Related]
16. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
[TBL] [Abstract][Full Text] [Related]
17. Telithromycin.
Balfour JA; Figgitt DP
Drugs; 2001; 61(6):815-29; discussion 830-1. PubMed ID: 11398913
[TBL] [Abstract][Full Text] [Related]
18. Telithromycin: the first ketolide for the treatment of respiratory infections.
Kasbekar N; Acharya PS
Am J Health Syst Pharm; 2005 May; 62(9):905-16. PubMed ID: 15851496
[TBL] [Abstract][Full Text] [Related]
19. Telithromycin (Ketek) for community-acquired respiratory tract infections.
Wimett L; Laustsen G
Nurse Pract; 2004 Sep; 29(9):56-60. PubMed ID: 15359148
[No Abstract] [Full Text] [Related]
20. Telithromycin versus clarithromycin for the treatment of community-acquired respiratory tract infections: a meta-analysis of randomized controlled trials.
Li XM; Wang FC; Yang F; Jin YH
Chin Med J (Engl); 2013; 126(11):2179-85. PubMed ID: 23769580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
